Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Chengdu Kanghua Biological Products Co., Ltd. (referred to as "Kangh"), established in 2004, stands as one of the 13 enterprises in Chengdu Economic and Technological Development Zone with full vaccine production capacity. Kangh's core business encompasses research, development, production, sales, and technical services related to biological products for prevention. The company's product portfolio includes Group ACYW135 Mening...
Chengdu Kanghua Biological Products Co., Ltd. (referred to as "Kangh"), established in 2004, stands as one of the 13 enterprises in Chengdu Economic and Technological Development Zone with full vaccine production capacity. Kangh's core business encompasses research, development, production, sales, and technical services related to biological products for prevention. The company's product portfolio includes Group ACYW135 Meningococcal Polysaccharide Vaccine-Maikexin and Rabies Vaccine (human diploid cell) for Human Use in freeze-dried form (HDCV).

List your booth number for exhibitions, ask us